Skip to main content

Bilan d’extension nécessaire après découverte d’une métastase d’un cancer du sein

  • Chapter
Cancer du sein en situation métastatique
  • 228 Accesses

Résumé

Le cancer du sein est le cancer le plus fréquent chez la femme dans les pays développés avec 50 000 nouveaux cas par an en France et environ 10 000 morts chaque année. La très grande majorité des décès en rapport avec un cancer du sein est due à des métastases, en particulier osseuses, pulmonaires, hépatiques et cérébrales. Le processus métastatique est un processus complexe comprenant l’invasion de cellules tumorales à travers la membrane basale, leur passage dans le système vasculaire, la survie de ces cellules tumorales dans la circulation sanguine, la colonisation de la paroi vasculaire et l’extravasation des cellules tumorales dans les organes cibles, et enfin la croissance tumorale au sein des organes cibles pour former une métastase (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Lu X, Kang Y (2007) Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia 12: 153–162

    Article  PubMed  Google Scholar 

  2. Porter GJR, Evans AJ, Pinder SE et al. (2004) Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 59: 1094–1098

    Article  PubMed  CAS  Google Scholar 

  3. Perrotin F, Marret H, Bouquin R, Fischer-Perrotin N, Lansac J, Body G (2001) Incidence, diagnostic et pronostic des métastases ovariennes du cancer du sein. Gynecol Obstet Fertil 29: 308–315

    Article  PubMed  CAS  Google Scholar 

  4. Hess KR, Varadhachary GR, Taylor SH et al. (2006) Metastatic patterns in adenocarcinoma. Cancer 106: 1624–1633

    Article  PubMed  Google Scholar 

  5. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22: 2942–2953

    Article  PubMed  Google Scholar 

  6. Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET/CT, and breast cancer imaging. Radiographics 27: 215–229

    Article  Google Scholar 

  7. Sheafor DH, Frederick MG, Paulson EK, Keogan MT, Delong DM, Nelson RC (1999) Comparison of unenhanced, hepatic arterial-dominant and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR 172: 961–968

    PubMed  CAS  Google Scholar 

  8. Fennessy FM, Mortele KJ, Kluckert T et al. (2004) Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR 182: 651–655

    PubMed  Google Scholar 

  9. Nishino M, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S (2003) Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR 180: 129–134

    PubMed  Google Scholar 

  10. Khalil HI, Patterson SA, Panicek DM (2005) Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 235: 872–878

    Article  PubMed  Google Scholar 

  11. Patterson SA, Khalil HI, Panicek DM (2006) MRI evaluation of small hepatic lesions in women with breast cancer. AJR 187: 307–212

    Article  PubMed  Google Scholar 

  12. Jung JI, Kim HH, Park SH et al. (2004) Thoracic manifestations of breast cancer and ist therapy. Radiographics 24: 1269–1285

    Article  PubMed  Google Scholar 

  13. Casey JJ, Stempel BG, Scanlon EF, Wa F (1984) The solitary pulmonary nodule in the patient with breast cancer. Surgery 96: 801–805

    PubMed  CAS  Google Scholar 

  14. Lee SS, Ahn JH, Kim MK et al. (2008) Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 111: 523–530

    Article  PubMed  Google Scholar 

  15. Chinot O (2006) Métastases cérébrales. Rev Prat 56: 1799–1804

    PubMed  Google Scholar 

  16. Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22: 3608–3617

    Article  PubMed  Google Scholar 

  17. Kreusel KM, Wiegel T, Stange M, Bornfeld N, Foerster MH (2000) Intraocular metastases of metastatic breast carcinoma in the woman. Incidence, risk factors and therapy. Ophthalmologe 97: 342–346

    Article  PubMed  CAS  Google Scholar 

  18. Grassetto G, Fornasiero A, Bonciarelli G et al. (2009) Additional value of FDG-PET/CT in management of “solitary” liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Bio 8

    Google Scholar 

  19. Sant M (2001) Differences in stage and therapy for breast cancer across Europe. Int J Cancer 93: 894–901

    Article  PubMed  CAS  Google Scholar 

  20. Bruneton JN, Balu-Maestro C, Raffaeli C, Mourou MY, Cambon P, Granon C (1996) Indications for hepatic ultrasonography in breast cancer staging and follow up. Breast Cancer Res Treat 37: 165–121

    Article  Google Scholar 

  21. Chen EA, Carlson GA, Coughlin BF, Reed WP, Garg JL, Frank JL (2000) Routine chest roentgenography in unnecessary in the work-up of stage I et II breast cancer. J Clin Oncol 18: 3503–3506

    PubMed  CAS  Google Scholar 

  22. Ciatto S, Pacini P, Azzini V et al. (1988) Preoperative staging of primary breast cancer. A multicentric study. Cancer 61: 1038–1040

    Article  PubMed  CAS  Google Scholar 

  23. Cox M, Gilliland R, Odling Smee GW Spencer RA (1992) An evaluation of radionuclide scanning and liver ultrasonography for staging breast cancer. Austr NZ J Surg 32: 550–555

    Article  Google Scholar 

  24. Gerber B, Seitz E, Müller H et al. (2003) Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat 82: 29–37

    Article  PubMed  Google Scholar 

  25. Ravaioli A, Pasini G, Polselli A et al. (2002) Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat 72: 53–60

    Article  PubMed  Google Scholar 

  26. Khatcheressian JL, Wolff AC, Smith TJ et al. (2006) American Society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24: 5091–5097

    Article  PubMed  Google Scholar 

  27. The GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 271: 1587–1592

    Article  Google Scholar 

  28. Rosselli Del Turco M, Palli D, Cariddi et al. (1994) Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271: 1593–1597

    Article  PubMed  CAS  Google Scholar 

  29. Rojas MP, Telaro E, Russo A et al. (2000) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 4: CD001768

    PubMed  Google Scholar 

  30. Whitlock JP, Evans AJ, Jackson L, Chan SY, Robertson JF (2001) Imaging of metastatic breast cancer: distribution and radiological assessment at presentation. Clin Oncol 13: 181–186

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France

About this chapter

Cite this chapter

Taourel, P., Cyteval, C. (2010). Bilan d’extension nécessaire après découverte d’une métastase d’un cancer du sein. In: Cancer du sein en situation métastatique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0076-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0076-9_4

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0075-2

  • Online ISBN: 978-2-8178-0076-9

Publish with us

Policies and ethics